Abstract
Characterization of tumor-to-normal endogenous optical contrast from 3D diffuse optical tomography, neoadjuvant chemotherapy monitoring with additional blood flow information, and 3D fluorescence DOT with exogenous contrast agent injection are presented.
| Original language | English |
|---|---|
| Pages | BSuB1 |
| DOIs | |
| State | Published - 2008 |
| Event | Biomedical Optics, BIOMED 2008 - St. Petersburg, FL, United States Duration: 16 Mar 2008 → 19 Mar 2008 |
Conference
| Conference | Biomedical Optics, BIOMED 2008 |
|---|---|
| Country/Territory | United States |
| City | St. Petersburg, FL |
| Period | 16/03/08 → 19/03/08 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'In vivo breast cancer characterization and therapy monitoring using diffuse optical methods based on endogenous optical/exogenous fluorescence contrast'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver